Alliance for Safe Biologic Medicines

Web site: www.safebiologics.org

AfPA_graphic

bulletAbout the Alliance for Safe Biologic Medicines

The Alliance for Safe Biologic Medicines is an organization composed of diverse healthcare groups and individuals—from patients to physicians, innovative medical biotechnology companies and others who are working together to ensure patient safety is at the forefront of the biosimilars policy discussion. Their membership list and steering committee reflect the wide range of voices within the healthcare community. Their coalition ultimately strives to position itself to be an authoritative resource center of information for the healthcare and policy communities.

bulletNews and Items of Interest

What doctors need to know when pharmacists substitute biological medicines - Video
What doctors need to know when
pharmacists substitute biological medicines

What Is Indication Extrapolation and Should It Be Allowed With Biological Medications? (Sept. 2014)

The Pharma Letter article "US health advocacy groups state case on biosimilars naming policy"

Inside Health Policy article "Stakeholders Gear Up For Biosimilar Substitution Battle In 2013" that mentions ASBM and quotes Dr. Dolinar

ASBM Paper on Biosimilar Naming Published in the Food and Drug Law Institute's Policy Forum

ASBM Statement on Automatic Substitution

ASBM and ASBM Members Sent Letters to FDA on Naming

Survey Reveals Key Safety Concern Associated with Biosimilar Naming; Urges Distinct Naming Requirement

bulletLetters supported by ICAN